Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.

CREBBP is targeted by inactivating mutations in follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). Here, we provide evidence from transgenic mouse models that Crebbp deletion results in deficits in B-cell development and can cooperate with Bcl2 overexpression to promote B-cell lymphoma. Through transcriptional and epigenetic profiling of these B cells, we found that Crebbp inactivation was associated with broad transcriptional alterations, but no changes in the patterns of histone acetylation at the proximal regulatory regions of these genes. However, B cells with Crebbp inactivation showed high expression of Myc and patterns of altered histone acetylation that were localized to intragenic regions, enriched for Myc DNA binding motifs, and showed Myc binding. Through the analysis of CREBBP mutations from a large cohort of primary human FL and DLBCL, we show a significant difference in the spectrum of CREBBP mutations in these 2 diseases, with higher frequencies of nonsense/frameshift mutations in DLBCL compared with FL. Together, our data therefore provide important links between Crebbp inactivation and Bcl2 dependence and show a role for Crebbp inactivation in the induction of Myc expression. We suggest this may parallel the role of CREBBP frameshift/nonsense mutations in DLBCL that result in loss of the protein, but may contrast the role of missense mutations in the lysine acetyltransferase domain that are more frequently observed in FL and yield an inactive protein.

[1]  K. Basso,et al.  The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma. , 2017, Cancer discovery.

[2]  Ryan D. Morin,et al.  Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study , 2016, PLoS medicine.

[3]  Klaus Hansen,et al.  An interactive environment for agile analysis and visualization of ChIP-sequencing data , 2016, Nature Structural &Molecular Biology.

[4]  M. Lunning,et al.  Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas , 2015, Blood Cancer Journal.

[5]  D. Karolchik,et al.  The UCSC Genome Browser database: 2016 update , 2015, bioRxiv.

[6]  L. Pasqualucci,et al.  The genetic landscape of diffuse large B-cell lymphoma. , 2015, Seminars in hematology.

[7]  Ash A. Alizadeh,et al.  Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation , 2015, Proceedings of the National Academy of Sciences.

[8]  Chunxu Qu,et al.  Genome-wide and single-cell analyses reveal a context dependent relationship between CBP recruitment and gene expression , 2014, Nucleic acids research.

[9]  W. C. Chan,et al.  Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma , 2014, Nature Communications.

[10]  L. Staudt,et al.  Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. , 2014, Blood.

[11]  Raul Rabadan,et al.  Genetics of follicular lymphoma transformation. , 2014, Cell reports.

[12]  Chia-Lin Wei,et al.  Interactome Maps of Mouse Gene Regulatory Domains Reveal Basic Principles of Transcriptional Regulation , 2013, Cell.

[13]  M. Calaminici,et al.  Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma , 2013, Nature Genetics.

[14]  Charles Y. Lin,et al.  Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. , 2013, Cancer cell.

[15]  J. Briones,et al.  MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy , 2013, Haematologica.

[16]  B. Ren,et al.  Mapping Human Epigenomes , 2013, Cell.

[17]  Steven J. M. Jones,et al.  Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. , 2013, Blood.

[18]  L. Pasqualucci The genetic basis of diffuse large B-cell lymphoma , 2013, Current opinion in hematology.

[19]  Ash A. Alizadeh,et al.  Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. , 2012, Blood.

[20]  J. Dekker,et al.  Hi-C: a comprehensive technique to capture the conformation of genomes. , 2012, Methods.

[21]  Kai Fu,et al.  Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. , 2012, Cancer cell.

[22]  Paul K. Brindle,et al.  Is histone acetylation the most important physiological function for CBP and p300? , 2012, Aging.

[23]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[24]  Eric S. Lander,et al.  Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing , 2012, Proceedings of the National Academy of Sciences.

[25]  Alberto Termanini,et al.  Fish the ChIPs: a pipeline for automated genomic annotation of ChIP-Seq data , 2011, Biology Direct.

[26]  A. Ariza,et al.  Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas , 2011, Histopathology.

[27]  W. Chan,et al.  Gains of MYC locus and outcome in patients with diffuse large B‐cell lymphoma treated with R‐CHOP , 2011, British journal of haematology.

[28]  Steven J. M. Jones,et al.  Frequent mutation of histone modifying genes in non-Hodgkin lymphoma , 2011, Nature.

[29]  Raul Rabadan,et al.  Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma , 2011, Nature Genetics.

[30]  G. Lenz,et al.  Pathogenesis of non-Hodgkin's lymphoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Kenneth H. Buetow,et al.  CREBBP mutations in relapsed acute lymphoblastic leukaemia , 2011, Nature.

[32]  G. Zambetti,et al.  Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathways , 2011, Cell cycle.

[33]  Raul Rabadan,et al.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma , 2010, Nature.

[34]  Sonali M. Smith,et al.  The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma. , 2010, Blood cells, molecules & diseases.

[35]  Jianmin Wang,et al.  CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation , 2010, The EMBO journal.

[36]  Michael Q. Zhang,et al.  Combinatorial patterns of histone acetylations and methylations in the human genome , 2008, Nature Genetics.

[37]  M. Reth,et al.  Testing gene function early in the B cell lineage in mb1-cre mice , 2006, Proceedings of the National Academy of Sciences.

[38]  J. Rehg,et al.  Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells. , 2006, Blood.

[39]  Kajia Cao,et al.  BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. , 2004, The American journal of pathology.

[40]  E. Stauber,et al.  Proteomics of Chlamydomonas reinhardtii Light-Harvesting Proteins , 2003, Eukaryotic Cell.

[41]  E. Miska,et al.  Acetylation of β-Catenin by CREB-binding Protein (CBP)* , 2002, The Journal of Biological Chemistry.

[42]  David Botstein,et al.  Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[44]  Jerry L. Workman,et al.  Expanded Lysine Acetylation Specificity of Gcn5 in Native Complexes* , 1999, The Journal of Biological Chemistry.

[45]  C. Allis,et al.  Overlapping but Distinct Patterns of Histone Acetylation by the Human Coactivators p300 and PCAF within Nucleosomal Substrates* , 1999, The Journal of Biological Chemistry.

[46]  A. Zelenetz,et al.  Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis. , 1991, Blood.

[47]  A. Strasser,et al.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.

[48]  C. Croce,et al.  The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. , 1985, Science.

[49]  O. Elemento,et al.  CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas. , 2017, Cancer discovery.

[50]  Terrence S. Furey,et al.  The UCSC Genome Browser Database , 2003, Nucleic Acids Res..

[51]  E. Miska,et al.  Acetylation of beta-catenin by CREB-binding protein (CBP). , 2002, The Journal of biological chemistry.

[52]  Jan O. Korbel,et al.  Finding Transcription Factor Binding Sites in Coregulated Genes by Exhaustive Sequence Search , 2000, German Conference on Bioinformatics.